Cc1ccc(-c2cc(-c3ccc(Cl)cc3)nc(/N=C3\C(=O)N(CN4CCOCC4)c4ccc(Cl)cc43)n2)cc1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?